This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cramer's 'Mad Money' Recap: Shopping for Stocks

Click here for an archive of Cramer's "Mad Money" recaps.


If the market offers a good price on a high-quality stock next week, take it, Jim Cramer told viewers of his "Mad Money" TV show Friday.

Cramer says investors need to prepare for next week by noting all the companies they like on a shopping list and the price they would like to buy them at. Amid all of the volatility, he emphasizes, there are opportunities in this volatile market if home gamers are ready to take advantage of them.

Cramer cites ConocoPhillips (COP), a stock that he owns for his charitable trust, Action Alerts PLUS, as one such opportunity.

Earlier this week, he says, Conoco traded at $69 a share before going to $76 two days later. Because Conoco was on Cramer's list, he knew that $69 was the price he wanted and was able to take advantage of the move.

Cramer also notes Procter & Gamble (PG), the company with the best record of dividend increases on the Dow Jones Industrial Average, which recently was trading as low as $63 a share.

He also likes Altria (MO), another Action Alerts PLUS stock, which yields 4.25% at its current price of $70 a share.

The list also includes AT&T (T), Wells Fargo (WFC), Bear Stearns (BSC) and Toll Brothers (TOL). All of these are quality stocks trading at very low levels, he noted.

Cramer also likes Schering-Plough (SGP), which has recently been cut in half. It went down again on Friday after the FDA announced plans to review a study of its controversial cholesterol-lowering drug Vytorin that the agency had approved.

Cramer says at just $18 a share, Schering is priced as if it will never sell another prescription for Vytorin again, and this is just not the case.

The situation reminds Cramer of Bauch & Lomb, and how a tainted contact lens solution pulled the stock down to just $43 a share before it received a takeover bid at $65 a share.

Cramer said regardless of what actions the Federal Reserve takes next week, investors should pull the trigger if the stocks they want to own hit the prices they want.

Fighting Diabetes

Cramer says Allergan (AGN) is no longer known for just breast implants and Botox, and he's a buyer.

Citing an article in The New York Times, Cramer notes that gastric banding surgeries are helping patients with Type 2 diabetes lose weight and live longer. As a result, Allergan's own proprietary gastric banding system, LAP-Band, should flourish.

Cramer also likes Allegran for its recession-proof nature, saying it can deliver solid earnings in just about any economic environment. The company also recently announced a new skin-care line it is developing with Clinique, a move that should bolster earnings.

Noting that the stock is down 9% from it's recent highs, Cramer says he'd either wait until after the company reports its earnings next week to establish a position, or would buy half a position now and the other half after earnings.

Over the long term, Cramer says Allergan is a strong investment.

Why the Sirius Merger Makes Sense

For speculation Friday, Cramer recommended Sirius Satellite Radio (SIRI) on the premise that the proposed merger with XM Satellite Radio (XMSR) will be approved sometime within the next two months.

He says there's no reason why the FCC should be dragging its feet or blocking the deal. Cramer sees a 75% chance that the deal will be approved, but likes Sirius as a stand-alone company as well.

Cramer cites three reasons why Sirius merger should be approved. First, the combined company would offer more a la carte options than any other medium.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,039.49 +60.36 0.36%
S&P 500 1,992.37 +5.86 0.30%
NASDAQ 4,532.1040 +5.6220 0.12%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs